Empagliflozin vs Trimethoprim
Empagliflozin vs Trimethoprim: Overview
This comparison examines the pharmacological differences between Empagliflozin and Trimethoprim.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Trimethoprim β 8-10 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Trimethoprim β C14H18N4O3.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Trimethoprim β 290.3180 g/mol.
Type: Empagliflozin β Small molecule; Trimethoprim β Small molecule.